Clinical Trial on the Treatment of Stent Underexpansion Caused by Calcification Using Intravascular Lithotripsy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChina National Center for Cardiovascular Diseases

About this trial

Our aim is to investigate the efficacy and safety of intravascular lithotripsy(IVL) in the treatment of stent underexpansion caused by calcification through a prospective, multicenter, randomized controlled trial. Patients with inadequate stent expansion due to calcification detected by intravascular ultrasound(IVUS) were randomly divided into two groups. The experimental group received IVL in addition to high-pressure balloon post-dilation, while the control group only received high-pressure balloon post-dilation. Follow up for 1 year is conducted to determine the safety and efficacy of IVL application based on the primary efficacy endpoint, key secondary efficacy endpoint, other secondary efficacy endpoint, and safety endpoint.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age range: 18-80 years old, male or non pregnant female

The patient or guardian can voluntarily sign and understand the informed consent form, and can accept follow-up

Asymptomatic ischemic, stable or unstable angina or myocardial infarction (MI) (including ST segment elevation and non ST segment elevation MI) with chest pain onset to hospital admission time>24 hours, as well as old myocardial infarction patients

Visually assess the target lesion with a reference vessel diameter of 2.5-4.0mm, diameter stenosis degree ≥ 70% or ≥ 50%, and evidence of ischemia

Disqualifiers

Individuals with abnormal coagulation function tests

Patients with severe hemodynamic disorders

Clinical manifestations of heart failure with LVEF<30%

I have experienced an acute myocardial infarction in the past week

Trial design

Design model

Parallel

Treatments tested in this trial

  • intravascular lithotripsy

    Device

    The intravascular lithotripsy can intermittently release acoustic pressure waves at the site of vascular calcification lesions, thereby achieving the goal of rupturing calcified plaques; After the rupture of calcified plaques, the vascular calcification lesions can be fully dilated with the help of lower balloon inflation pressure.

  • high-pressure ballon

    Device

    High pressure balloon dilation, as the main method for traditional treatment of insufficient stent expansion caused by calcification, has a good therapeutic effect on insufficient stent expansion caused by calcification

Treatment groups

222 Participants
are divided into 2 treatment groups
Group A: experimental groupExperimental treatment 1 intervention
Group B: control groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Satisfaction Rate of Stent Expansion[Effcacy]

Satisfied stent expansion is defined as meeting the standard of good expansion after stent implantation through IVUS after PCI

Time frame
immediately after percutaneous coronary intervention(PCI)

Secondary outcomes

1

Major Cardiovascular Events[Effcacy]

a composite endpoint of cardiovascular death, target vessel myocardial infarction and target vessel revascularization

Time frame
1 year after after percutaneous coronary intervention(PCI)
2

Lumen Obtainment after PCI[Effcacy]

changes in lumen area after treatment

Time frame
immediately after percutaneous coronary intervention(PCI)
3

Incidence of Treatment-Emergent Complications[Safety]

Postoperative complications such as coronary spasm, dissection, acute occlusion, persistent ventricular arrhythmia, etc

Time frame
immediately after percutaneous coronary intervention(PCI)

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: